Newsfeeds Archive - Spark Newswire

1 minute read

Bankrupt Generic Drugmaker Endo Secures Court Approval for $600M Opioid Epidemic Compensation Plan

January 11, 3:09 PM

Endo International (OTC: ENDPQ) has gained approval from U.S. Bankruptcy Court Judge James Garrity to initiate the solicitation of votes for its restructuring plan.

ENDPQ

1 minute read

Generic Drugmaker Endo’s Bankruptcy: Lenders Suggest $465M Payment To Settle Dispute With Federal Entities: Report

By Vandana Singh

November 22, 7:56 AM

Endo International's (OTC: ENDPQ) lenders have reportedly proposed a fresh deal to settle with U.S.

ENDPQ

2 minute read

Rite Aid Once Top Drugstore Chain Lost Over 80% Of Stock Value In One Year: Opioid Litigation Takes Toll

By Vandana Singh

August 25, 1:52 PM

Rite Aid Corp (NYSE: RAD) is reportedly on the brink of filing for bankruptcy amidst many lawsuits over its purported role in the opioid crisis to address its significant debt burden, which exceeds $3.3 billion, through a Chapter 11 filing.

ACI

2 minute read

Endo And Premier, Inc. Collaborate To Address Pitocin (Oxytocin Injection, USP) Shortage

By Benzinga Newsdesk

July 17, 4:31 PM

Strategic effort aims to bring stable, quality supply to providers and enhanced pricing predictability for critical labor and delivery drugCHARLOTTE, N.C. and DUBLIN, July 17, 2023 /PRNewswire/ -- Endo International plc

ENDPQ

5 minute read

Elon Musk Tells Employees Tesla Will Be ‘Most Valuable Company On Earth, Sam Bankman-Fried Set To Enter Plea On Fraud Case, Twitter ‘Should Feel Faster’: Today’s Top Stories

By Vandana Singh

December 29, 8:59 AM

Reuters

$BNB

1 minute read

Novartis Settles Antitrust Cases Related To Generic Entry For Hypertension Drug

By Vandana Singh

December 29, 8:18 AM

Novartis AG (NYSE: NVS) will pay $245 million to end antitrust litigation accusing the company of trying to delay the U.S. launch of generic versions of its Exforge, which treats hypertension to lower blood pressure and reduce the risk of strokes.

CVS